MISTI MORGAN: Open Payments
NPI 1073069589 · COUSHATTA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 19 payments from 8 companies in 2025. Trend: 2023 $551 · 2024 $437 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $117 |
| Astellas Pharma US Inc | 5 | $80 |
| Organon LLC | 2 | $45 |
| MILLICENT US INC | 2 | $40 |
| Sage Therapeutics, LLC | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
Products named: MYFEMBREE, Veozah, NEXPLANON, INTRAROSA, ZURZUVAE, GEMTESA, Auvelity, The Cologuard Plus Collection Kit.
Industry payments across LA — which companies pay providers there.
